.

Agenus reported $-44565000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Agenus AGEN:US $ -44.56M 9.1M
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 44.27B 22.58B
Bristol Myers Squibb BMY:US $ 2590M 37M
Celldex Therapeutics CLDX:US $ -36.4M 13.14M
Chemocentryx CCXI:US $ -31.57M 6.66M
CSL CSL:AU $ 1.03B 2.02B
Dynavax Technologies DVAX:US $ 128.23M 97.46M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Genocea Biosciences GNCA:US $ -15.77M 2.36M
Gilead Sciences GILD:US $ 2029M 1832M
Glaxosmithkline GSK:US $ 1081M 1720M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Immunogen IMGN:US $ -61.05M 38.2M
Intrexon XON:US $ -24.16M 6.27M
Jiangsu Hengrui Me. 600276:CH CH 1.03B 332.82M
Johnson & Johnson JNJ:US $ 5840M 22M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Merck MRK:GR € 1177M 4M
Merk MRK:US $ 4927M 642M
Northwest Biotherapeutics NWBO:US -21209000 9.33M
Novartis NOVN:VX 2.23B 624M
Novavax NVAX:US $ -482.96M 692.25M
Pfizer PFE:US $ 12102M 2229M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Rigel Pharmaceuticals RIGL:US $ -12.96M 13.3M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Veracyte VCYT:US $ -10.73M 4.51M
YTE INCY:US $ 254.43M 137.89M